Majem M, Goldman JW, John T, Grohe C, Laktionov K, Kim SW, Kato T, Vu HV, Lu S, Li S, Lee KY, Akewanlop C, Yu CJ, de Marinis F, Bonanno L, Domine M, Shepherd FA, Atagi S, Zeng L, Kulkarni D, Medic N, Tsuboi M, Herbst RS, Wu YL.
. Health-Related Quality of Life Outcomes in Patients with Resected Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer Who Received Adjuvant Osimertinib in the Phase III ADAURA Trial
. Clin Cancer Res.
2022.
Department : Medicine
Journal Name : Clin Cancer Res Source : Pubmed
Maluangnon C., Tongyoo S., Permpikul C.
. Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
. Infection and Drug Resistance.
2022.
15
7751-7760.
Department : Medicine
Journal Name : Infection and Drug Resistance Source : Scopus